Viatris Inc. and Atomo Diagnostics Announce Agreement with Unitaid to Expand Access to HIV Self-Test

Cost of the test will be reduced to improve access and stimulate demand in 135 low- and middle-income countries PITTSBURGH and SYDNEY, April 29, 2021 /PRNewswire/ — Viatris Inc. and Atomo Diagnostics Limited (ASX:AT1) (Atomo) today announced a multi-year agreement with global health agency Unitaid to expand access to HIV self-testing in low- and middle-income […]

Viatris Inc. and Atomo Diagnostics Announce Agreement with Unitaid to Expand Access to HIV Self-Test Read More